Facebook Twitter LinkedIn Google Plus RSS

Aerie Pharmaceuticals names new COO

By ,

Bedminster-based Aerie Pharmaceuticals Inc. announced Monday it has named Thomas Mitro president and chief operating officer. Mitro's appointment is effective immediately.

According to the company, prior to joining Aerie, Mitro most recently served as vice president of sales and marketing at Omeros Corp., a publicly traded clinical-stage biopharmaceutical company. He was also vice president for sales and marketing at ISTA Pharmaceuticals.

Aerie named new chief executive Vicente Anido Jr. in July.

Digital content editor Joe Ross is @joeross on Twitter.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy